Intra-Cellular Therapies Inc (OQ:ITCI)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for ITCI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/19 May 14/19 Alafi Christopher D Indirect Ownership Common Stock P - Open market or private purchase 100,000 $12.56
Apr 2/19 Mar 31/19 Alafi Christopher D Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,190 $12.18
Apr 2/19 Mar 31/19 Van Nostrand Robert L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 478 $12.18
Apr 2/19 Mar 31/19 Riggs Rory B Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,190 $12.18
Apr 2/19 Mar 31/19 Lerner Richard A Indirect Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,128 $12.18
Mar 1/19 Feb 27/19 Hineline Lawrence J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -400  
Mar 1/19 Feb 27/19 Hineline Lawrence J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Mar 1/19 Feb 27/19 Hineline Lawrence J. Direct Ownership Common Stock S - Open market or private sale -1,000 $15.00
Mar 1/19 Feb 27/19 Hineline Lawrence J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 400 $2.74
Mar 1/19 Feb 27/19 Hineline Lawrence J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $2.74
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ITCI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 25th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/19 May 14/19 Alafi Christopher D Indirect Ownership Common Stock P - Open market or private purchase 100,000 $12.56
Apr 2/19 Mar 31/19 Alafi Christopher D Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,190 $12.18
Apr 2/19 Mar 31/19 Van Nostrand Robert L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 478 $12.18
Apr 2/19 Mar 31/19 Riggs Rory B Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,190 $12.18
Apr 2/19 Mar 31/19 Lerner Richard A Indirect Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,128 $12.18
Mar 1/19 Feb 27/19 Hineline Lawrence J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -400  
Mar 1/19 Feb 27/19 Hineline Lawrence J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Mar 1/19 Feb 27/19 Hineline Lawrence J. Direct Ownership Common Stock S - Open market or private sale -1,000 $15.00
Mar 1/19 Feb 27/19 Hineline Lawrence J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 400 $2.74
Mar 1/19 Feb 27/19 Hineline Lawrence J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $2.74
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $ITCI

StockTwits